.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Dow
Julphar
Harvard Business School
Cerilliant
Cantor Fitzgerald
Accenture
Medtronic
Mallinckrodt

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074521

« Back to Dashboard

NDA 074521 describes DIPYRIDAMOLE, which is a drug marketed by Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Barr, Glenmark Generics, Idt Australia Ltd, Impax Labs, Lannett, Murty Pharms, Oxford Pharms, Purepac Pharm, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. It is available from ten suppliers. Additional details are available on the DIPYRIDAMOLE profile page.

The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.

Summary for 074521

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 074521

Physiological EffectDecreased Platelet Aggregation

Medical Subject Heading (MeSH) Categories for 074521

Suppliers and Packaging for NDA: 074521

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIPYRIDAMOLE dipyridamole INJECTABLE;INJECTION 074521 ANDA West-ward Pharmaceutical Corp. 0641-2569 0641-2569-44 5 VIAL in 1 CARTON (0641-2569-44) > 10 mL in 1 VIAL (0641-2569-41)
DIPYRIDAMOLE dipyridamole INJECTABLE;INJECTION 074521 ANDA General Injectables & Vaccines, Inc 52584-569 52584-569-41 1 VIAL, SINGLE-DOSE in 1 BAG (52584-569-41) > 10 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/ML
Approval Date:Oct 18, 1996TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Fuji
Deloitte
Daiichi Sankyo
UBS
Chinese Patent Office
Dow
Baxter
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot